Handelsbanken Fonder Ab Teva Pharmaceutical Industries LTD Transaction History

Handelsbanken Fonder Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$7.38 - $10.4 $195,570 - $275,600	-26,500 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$10.34 - $12.81 $22,748 - $28,182	-2,200 Reduced 7.67%	26,500 $306,000
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $233,043 - $376,544	28,700 New	28,700 $354,000
Q1 2019 May 10, 2019	SELL	$15.58 - $20.01 $701,100 - $900,450	-45,000 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$14.59 - $23.84 $328,275 - $536,400	22,500 Added 100.0%	45,000 $694,000
Q3 2018 Oct 23, 2018	BUY	$21.06 - $25.65 $473,850 - $577,125	22,500 New	22,500 $485,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.